Recommendations—benefits and risks of T therapyLoEGrade
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome3A
T therapy improves sexual desire, erectile function, and sexual satisfaction1A
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy2A
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo2A
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician3A
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary1bB
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management2A
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period2B
Recommendations—benefits and risks of T therapyLoEGrade
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome3A
T therapy improves sexual desire, erectile function, and sexual satisfaction1A
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy2A
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo2A
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician3A
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary1bB
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management2A
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period2B
Recommendations—benefits and risks of T therapyLoEGrade
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome3A
T therapy improves sexual desire, erectile function, and sexual satisfaction1A
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy2A
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo2A
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician3A
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary1bB
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management2A
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period2B
Recommendations—benefits and risks of T therapyLoEGrade
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome3A
T therapy improves sexual desire, erectile function, and sexual satisfaction1A
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy2A
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo2A
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician3A
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary1bB
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management2A
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period2B
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close